We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

DIASORIN

DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tes... read more Featured Products: More products

Download Mobile App




FDA Approval Adds Automated Testing Option for Parvovirus B19 Serology

By LabMedica International staff writers
Posted on 14 Oct 2026

Human Parvovirus B19 is a highly contagious erythrovirus transmitted mainly through respiratory droplets and close contact. More...

Diagnosis relies on IgM antibodies to detect active infection and IgG antibodies to indicate previous exposure and immune status. To support faster clinical decisions, a newly approved automated serology testing option provides same-day results for diagnosis, treatment, and patient guidance.

Diasorin has obtained U.S. Food and Drug Administration (FDA) approval for the LIAISON Biotrin Parvovirus B19 IgM Plus and LIAISON Biotrin Parvovirus B19 IgG Plus assays. The assays run on the Diasorin LIAISON XL immunoassay system and are available in the United States. They are described as the first fully automated diagnostic tests for Parvovirus B19 serology on the LIAISON XL.

The assays support serologic diagnosis by detecting Parvovirus B19-specific antibodies. The IgM assay is used to identify active infection, while the IgG assay indicates previous exposure and immune status. Together, the tests address a gap in FDA-approved automated Parvovirus B19 testing and expand access through the LIAISON family of analyzers.

This added testing capacity is clinically relevant because Parvovirus B19 infection can cause serious complications in pregnant women, immunocompromised individuals, and patients with chronic hemolytic disorders. Maternal infection can cross the placenta in approximately 30–50% of cases and may lead to severe fetal anemia, hydrops fetalis, miscarriage, or stillbirth. Although most infected pregnancies have favorable outcomes, high-risk cases may require intrauterine blood transfusion.

By providing same-day results, the new assays may support faster diagnosis and more timely treatment and patient guidance. The approval adds an automated option for clinical laboratories performing Parvovirus B19 serology in the United States. The available information did not report analytical performance metrics such as sensitivity, specificity, accuracy, or area under the curve.

“Because maternal Parvovirus B19 infection may result in serious fetal complications, timely serological testing of exposed pregnant women is critical to assess immune status, identify recent infection, and support appropriate clinical follow-up. We are excited to bring in another first automated testing solution to offer our clinicians same day results,” said Gabriele Allegri, Diasorin President, Immuno Division.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The MIRAM GAGome Kit quantifies urine CS disaccharides by UHPLC-MS/MS, supporting exploratory and translational research across disease areas. (Photo courtesy of Elypta)

Study Finds Urine Biomarker Score Improves Five-Year Cancer Risk Prediction

Cancer risk stratification in healthy adults often relies on established factors such as age and smoking history. However, several cancers highlighted in the study, including pancreatic, kidney, and brain... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.